Xencor Inc Intellectual Property Contracts & Agreements
9 Contracts & Agreements
- License Agreements (9 contracts)
- Fourth Amendment to the License Agreement by and between the Company and MorphoSys AG (Filed With SEC on May 9, 2024)
- Second Amendment to Option and License Agreement dated November 28, 2022 by and between the Company and Alexion Pharma International Operations Limited (as successor to Alexion... (Filed With SEC on February 27, 2023)
- First Amendment to Option and License Agreement dated June14, 2019 by and between the Company and Alexion Pharma Holding (as successor to Alexion Pharmaceuticals, Inc.) (Filed With SEC on February 27, 2023)
- Third Amendment to the License Agreement, dated July 13, 2020, by and between the Company and MorphoSys AG (Filed With SEC on February 24, 2021)
- Second Amendment to the License Agreement, dated January 8, 2020, by and between the Company and MorphoSys AG (Filed With SEC on February 24, 2021)
- First Amendment to the Research and License Agreement, dated November 22, 2019, by and between the Company and Amgen Inc (Filed With SEC on February 24, 2021)
- RESEARCH AND LICENSE AGREEMENT (Filed With SEC on November 4, 2015)
- OPTION AND LICENSE AGREEMENT (Filed With SEC on October 25, 2013)
- OPTION AND LICENSE AGREEMENT (Filed With SEC on October 11, 2013)
